Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease

Dipeptidyl Peptidase IV and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) study

(2010) V. C. Luft et al.   DIABETES CARE

Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease

(2010) Kevin C. Miranda et al.   KIDNEY INTERNATIONAL

Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples

(2010) Javier Conde-Vancells et al.   Proteomics Clinical Applications

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats

(2008) Yasushi Kirino et al.   JOURNAL OF ENDOCRINOLOGY

Large-Scale Proteomics and Phosphoproteomics of Urinary Exosomes

(2008) P. A. Gonzales et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Diagnostic Value of the Aminopeptidase N, N-Acetyl-β-D-Glucosaminidase and Dipeptidylpeptidase IV in Evaluating Tubular Dysfunction in Patients with Glomerulopathies

(2008) Branka Mitic et al.   RENAL FAILURE

Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects

(2007) Aine M. McKillop et al.   DIABETES RESEARCH AND CLINICAL PRACTICE